Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients
Launched by RWTH AACHEN UNIVERSITY · Aug 1, 2011
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \> 18 years of age
- • minimum of 3 months of hemodialysis
- • written consent
- Exclusion Criteria:
- • chronic or acute bowel disease
- • soy bean allergy
- • active Vitamin K Supplementation
- • oral anticoagulation with vitamin K Antagonists (coumarins)
- • systemic therapy using steroids
- • positive history for thrombosis or embolism
- • pregnancy
About Rwth Aachen University
RWTH Aachen University is a prestigious research institution located in Aachen, Germany, renowned for its commitment to advancing science and technology through innovative research and education. As a clinical trial sponsor, RWTH Aachen University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research aimed at improving patient outcomes. The university collaborates with various healthcare stakeholders to facilitate the translation of scientific discoveries into effective therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements throughout the research process. With a focus on fostering knowledge exchange and driving clinical advancements, RWTH Aachen University plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aachen, Nrw, Germany
Aachen, Nrw, Germany
Erkelenz, Nrw, Germany
Patients applied
Trial Officials
Ralf Westenfeld, MD
Principal Investigator
University Clinic of the RWTH Aachen
Georg Schlieper, MD
Study Chair
University Clinic of the RWTH Aachen
Stefan Holzmann, MD
Study Chair
Dialysis Unit Erkelenz, Germany
Stephan Heidenreich, MD
Study Chair
KfH Dialysis Centre Aachen, Schurzelter Strasse
Juergen Floege, MD
Study Director
University Clinic of the RWTH Aachen
Thilo Krueger, MD
Study Chair
University Hospital of the RWTH Aachen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials